ITI Life Sciences Seeks to Fund Innovative Drug Discovery Programme based on Ubiquitin
Following the publication of its comprehensive foresighting report on Emerging Drug Targets, ITI Life Sciences issues a Call for Expressions of Interest from organisations or individuals with expertise in the field of ubiquitin Signalling. ITI Life Sciences has identified this area as having significant potential and seeks to fund research and development opportunities, which will form part of an innovative drug discovery programme. Responses are invited from companies, agencies, institutes, academia and individuals. No geographical restrictions apply and ITI Life Sciences welcomes responses to this call from non-UK organisations. ITI Life Sciences is committed to helping its partners achieve success and ensuring the successful onward commercialisation of programme outputs. The Ubiquitin Proteasome System (UPS) was discovered in 1980 and implicated in key protein degradation mechanisms via a small protein named Ubiquitin. A resultant Nobel prize in 2004 coincided in links with Ubiquitin to a range of additional key cellular functions and diseases including cancer, neurodegenerative, metabolic, inflammatory and infectious diseases. Detailed analysis by ITI Life Sciences of the scientific and commercial landscape has reinforced its belief that the UPS provides a rich source of emerging drug targets, yet it remains a relatively unexploited and largely uncharted area for drug discovery. ITI Life Sciences also believes that the generation of novel tools and reagents will play a pivotal role in promoting new breakthroughs in this area.
Most read news
Related link
Other news from the department science
These products might interest you

Blotting standards and reagents by Cytiva
Western blotting standards and reagents
Blotting the course to effective detection of proteins from sample preparation to analysis

Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

Greener Alternative Products by Merck
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.